Strategic Initiative

Slingshot members are tracking this corporate initiative:

Ethicon Announces Agreement To Acquire NeuWave Medical

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ Community voting in process

Additional Information

Additional Relevant Details  Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems. Their products are currently used by physicians in over half of the top cancer centers in the United States. This acquisition is consistent with the Johnson & Johnson Medical Devices' strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology. Financial terms of the transaction have not been disclosed.NeuWave Medical's ablation technology was originally developed by physicians and microwave scientists from the University of Wisconsin to maximize energy delivery to tissue, minimize invasiveness and provide physician-friendly workflow. NeuWave Medical's Certus 140 ablation system's high-powered computer and intuitive touchscreen interface enables activation of single or simultaneous multiple probe procedures for patients with soft tissue lesions. This allows physicians to effectively tailor ablations for lesions of varying shapes and sizes. NeuWave Medical's probe family includes conventional probes and the only Precision PR probe to limit the ablation length, allowing precise and controlled ablations.
http://www.prnewswir...
Additional Relevant Details Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems. Their products are currently used by physicians in over half of the top cancer centers in the United States. This acquisition is consistent with the Johnson & Johnson Medical Devices' strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology. Financial terms of the transaction have not been disclosed.NeuWave Medical's ablation technology was originally developed by physicians and microwave scientists from the University of Wisconsin to maximize energy delivery to tissue, minimize invasiveness and provide physician-friendly workflow. NeuWave Medical's Certus 140 ablation system's high-powered computer and intuitive touchscreen interface enables activation of single or simultaneous multiple probe procedures for patients with soft tissue lesions. This allows physicians to effectively tailor ablations for lesions of varying shapes and sizes. NeuWave Medical's probe family includes conventional probes and the only Precision PR probe to limit the ablation length, allowing precise and controlled ablations.
http://www.prnewswir...
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Mar 07, 2016
Projected Implementation:
Q1, 2016
Relevance Tracked Until:
Q2, 2016
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Acquisition, Precision Pr Probe, Surgical Oncology